| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 12/03/2008 | EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors |
| 12/03/2008 | EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use |
| 12/03/2008 | EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use |
| 12/03/2008 | EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol |
| 12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
| 12/03/2008 | CN101316616A Method of dynamic nuclear polarisation (DNP) using a trityl radical and a paramagnetic metal ion |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 12/03/2008 | CN100439365C Compounds and compositions as protein kinase inhibitors |
| 12/03/2008 | CN100439346C Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 12/02/2008 | US7459502 Pharmaceutical compositions comprising crosslinked polyamine polymers |
| 12/02/2008 | US7459454 Aminopyrazine derivatives and compositions |
| 12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
| 12/02/2008 | CA2469315C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 12/02/2008 | CA2305548C Prostaglandin agonists and their use to treat bone disorders |
| 11/27/2008 | WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation |
| 11/27/2008 | US20080293813 Compositions and Methods |
| 11/27/2008 | US20080293650 Fused Heterocyclic Compounds and Use Thereof |
| 11/27/2008 | US20080293633 Pharmaceutical Formulations, Methods, and Dosing Regimens for the Treatment and Prevention of Acute Coronary Syndromes |
| 11/27/2008 | US20080293626 Pigment epithelium-derived factor as a therapeutic agent for vascular leakage |
| 11/27/2008 | US20080293044 Melks as Modifiers of the Rac Pathway and Methods of Use |
| 11/27/2008 | US20080292698 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| 11/26/2008 | EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 11/26/2008 | EP1578428A4 Treating alcohol and or substance abuse by antagonizing alpha a2 drenergic receptors with weak dopamine blocking |
| 11/26/2008 | CN100436452C Pyrazole compounds useful as protein kinase inhibitors |
| 11/26/2008 | CN100435859C Methods and compositions for healing and repair of articular cartilage |
| 11/25/2008 | US7457685 Preparing for individualized dosage forms of medicaments |
| 11/25/2008 | US7456282 Famciclovir intermediate; reaction with diethyl malonate, reduction, esterification with acetic anhydride |
| 11/25/2008 | US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen |
| 11/25/2008 | US7456204 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 11/25/2008 | US7456178 Compounds, methods and pharmaceutical compositions for inhibiting PARP |
| 11/25/2008 | US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract |
| 11/25/2008 | CA2370565C Dermally applicable vitamin d-containing pharmaceutical compositions |
| 11/25/2008 | CA2320182C Compositions containing organic compounds |
| 11/20/2008 | WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 11/20/2008 | US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade |
| 11/20/2008 | US20080287664 Hsp60 from arthrobacter |
| 11/20/2008 | US20080287489 Ophthalmic compositions for treating ocular hypertension |
| 11/20/2008 | US20080287444 Pyrazole compounds useful as protein kinase inhibitors |
| 11/20/2008 | US20080287366 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 11/20/2008 | US20080286823 Apparatus and method to measure platelet contractility |
| 11/20/2008 | US20080286339 Using multi-segment device to deliver selective androgen and estrogen receptor modulators to women in order to relieve symptoms associated with menopause |
| 11/20/2008 | US20080286322 Methods and devices for the sustained release of multiple drugs |
| 11/20/2008 | US20080286278 Process for in vivo treatment of specific biological targets in bodily fluids |
| 11/19/2008 | EP1358213B1 Humanized antibodies that recognize beta amyloid peptide |
| 11/19/2008 | CN101305990A Use of EDG receptor binding agents in cancer |
| 11/18/2008 | US7452913 Patterns of enzyme inhibitors formed by dissolving compounds and isolation by precipitation |
| 11/18/2008 | US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 11/18/2008 | US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 11/18/2008 | US7452874 Thrombopoietin mimetics |
| 11/18/2008 | US7452864 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 11/18/2008 | US7452677 for the identification and isolation of chondrocytes, mesenchymal progenitor cells and embryonic stem cells for tissue engineering of cartilage; diseases related to joints, cartilage and atherosclerosis |
| 11/18/2008 | US7452555 Cocrystallization |
| 11/18/2008 | US7452535 Methods of treatment using CTLA-4 antibodies |
| 11/18/2008 | CA2516557C Triazole compounds useful in therapy |
| 11/18/2008 | CA2359640C Topical sprays |
| 11/18/2008 | CA2277901C Cleansing composition with separately dispensed cleansing base and benefit base wherein benefit base also comprises surfactant |
| 11/13/2008 | US20080280851 Oral Dosage Forms of Gemcitabine Derivatives |
| 11/13/2008 | US20080280816 Methods and pharmaceutical compositions for healing wounds |
| 11/13/2008 | US20080279873 Active immunization to generate antibodies to soluble a-beta |
| 11/13/2008 | US20080279870 ALK protein tyrosine kinase, cells and methods embodying and using same |
| 11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
| 11/13/2008 | US20080279843 Using concentration of inflammation marker protein as evaluative signal for enzyme inhibitor dispension; drug delivery and antidiabetic agents |
| 11/13/2008 | US20080279820 Compositions and Methods for Treating Burns |
| 11/13/2008 | US20080279795 Tertiary Amine Functional Complex Polyester Polymers And Methods Of Production And Use |
| 11/13/2008 | US20080279789 Synergistic mixture; prophylaxis and treatment of respiratory system disorders |
| 11/12/2008 | EP1624837A4 Apparatus and method for the treatment of infectious disease in keratinized tissue |
| 11/12/2008 | EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 11/12/2008 | CN101302204A Quinazolone compound, composition and application including the same |
| 11/12/2008 | CN101302180A 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 11/12/2008 | CN101301475A Peg化因子vii糖型 Peg factor vii sugar type |
| 11/12/2008 | CN101301329A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 11/12/2008 | CN101301285A Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition |
| 11/12/2008 | CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells. |
| 11/12/2008 | CN100431602C Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 11/12/2008 | CN100431540C Treatment of diabetes with thiazolidinedione and metformin |
| 11/11/2008 | US7449605 Drugs; therapy for kidney diseases; removal of bile acid; gastrointestinal disorders; core-shell polymer |
| 11/11/2008 | US7449582 particularly tyrosine kinase, serine-threonine kinases, and MAP kinases; cancer, nervous system disorders and autoimmune diseases; 6-phenyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidines, 3-phenyl-2-oxo-1,2-dihydro-[1,6]naphthyridines, and 3-phenyl-2-oxo-1,2-dihydroquinolines |
| 11/11/2008 | US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1 |
| 11/11/2008 | US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 11/06/2008 | US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 11/06/2008 | US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia |
| 11/06/2008 | US20080275033 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 11/06/2008 | US20080274122 Plks as Modifiers of the Beta Catenin Pathway and Methods of Use |
| 11/06/2008 | US20080274086 Use of Cxcr4 Protein Expression on the Surface of Stem Cells as a Marker for Tumor Tropic Potential |
| 11/05/2008 | EP1988397A1 Compositions and method for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 11/05/2008 | EP1643953A4 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 11/05/2008 | EP1549246A4 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 11/05/2008 | EP1505945B1 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 11/05/2008 | EP1200424B1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 11/05/2008 | CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 11/05/2008 | CN101297969A Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 11/05/2008 | CN101297807A The use of 5-HT4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 11/05/2008 | CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent |
| 11/05/2008 | CN100430410C Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 11/05/2008 | CN100430377C N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/05/2008 | CN100430056C Use of MGLUR5 antagonists for the treatment of GERD |
| 11/04/2008 | US7445779 Methods of modulating IFNy production |
| 11/04/2008 | US7445767 Using water soluble dyes; contrast media for fluorescence |
| 11/04/2008 | CA2443449C Pyrazole derivatives for treating hiv |
| 10/30/2008 | WO2004112717A3 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |